Recent evidence suggests that not all patient-derived colorectal cancer cell lines express ASCL2 (Jubb et al., 2006; Ziskin et al., 2013), which constitutes a natural but hitherto not encountered limit. This evidence concerns the gene ASCL2 and colorectal cancer.